Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum.
Sign Up to like & getrecommendations! Published in 2021 at "European heart journal"
DOI: 10.1093/eurheartj/ehab642
Abstract: Intravascular thrombus formation and embolization are among the most frequent events leading to a number of cardiovascular conditions with high morbidity and mortality. The underlying causes are stasis of the circulating blood, genetic and acquired… read more here.
Keywords: management drugs; personalized antithrombotic; towards personalized; devices across ... See more keywords
PO-465 Effect of pain management drugs in metastatic prostate cancer: in vitro studies
Sign Up to like & getrecommendations! Published in 2018 at "ESMO Open"
DOI: 10.1136/esmoopen-2018-eacr25.486
Abstract: Introduction Metastatic castration-resistant prostate cancer (mCRPC) presents no curative treatment, being the median life expectancy of this patients about 14–20 months. Docetaxel (Doc) remains the current first line treatment of mCRPC, increasing the median overall… read more here.
Keywords: management drugs; pain management; prostate cancer; effect ... See more keywords